New Dupixent® (dupilumab) Data in Patients as Young as Six Years Old With Moderate-to-Severe Atopic Dermatitis to Be Presented at WCPD and EADV ...Middle East

TARRYTOWN, N.Y. and PARIS, Sept. 21, 2021 /PRNewswire/ -- More than 30 presentations reinforce the role of Dupixent in targeting IL-4 and IL-13, key drivers of the type 2 inflammation underlying atopic dermatitis in children, adolescents and adults Results provide insight into the...

Hence then, the article about new dupixent dupilumab data in patients as young as six years old with moderate to severe atopic dermatitis to be presented at wcpd and eadv was published today ( Tuesday 21/09/2021 - 09:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Dupixent® (dupilumab) Data in Patients as Young as Six Years Old With Moderate-to-Severe Atopic Dermatitis to Be Presented at WCPD and EADV )

Also on site :

• North Korea says its latest weapons tests included missiles with cluster-bomb warheads
• 1987 No. 1 Hit Ranked Among 'Best Hair Metal Songs of All Time' Became a Powerful Anthem for Starting Over
• Man rescued after two weeks trapped in collapsed Mexico mine